SCHEMBL165930

SCHEMBL165930

O=C(O)Cc1ccc(S)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.62
CAMK2A Q9UQM7 1/20 0.62
AKR1B1 P15121 1/20 0.61
LMNA P02545 2/20 0.58
GAA P10253 2/20 0.58
TSHR P16473 2/20 0.58
ABCC4 O15439 1/20 0.58
PTGS1 P23219 1/20 0.58
HTT P42858 1/20 0.58
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
HSD17B10 Q99714 3/20 0.52
FFAR1 O14842 1/20 0.52
ANPEP P15144 1/20 0.52
ENPEP Q07075 1/20 0.52
POLB P06746 2/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 2/20 0.50
NSD2 O96028 1/20 0.50
GRK2 P25098 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1527709 1.00 CA2 (0.62) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL28029703 0.98 CA2 (0.60) CA2CAMK2AAKR1B1LMNAGAA
Methane SCHEMBL7998414 0.98 CA2 (0.60) CA2CAMK2AAKR1B1LMNAGAA
Ethylene Glycol SCHEMBL6230203 0.93 CA2 (0.56) CA2CAMK2AAKR1B1LMNAGAA
Ethylene Glycol SCHEMBL6231139 0.93 CA2 (0.56) CA2CAMK2AAKR1B1LMNAGAA
Alcohol SCHEMBL28296676 0.91 ALDH1A1 (0.55) CA2CAMK2AAKR1B1LMNAGAA
1,3-Propanediol SCHEMBL6343516 0.89 CA2 (0.52) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL21382094 0.89 CA2 (0.52) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL6235820 0.88 CA2 (0.50) CA2CAMK2AAKR1B1LMNAGAA
SCHEMBL69614 0.87 CA2 (0.79) CA2CAMK2AAKR1B1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12605695-B2 Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites BUNDESREPUBLIK DEUTSCHLAND, VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT UND ENERGIE, DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER BUNDESANSTALT FÜR MATERIALFORSCHUNG UND -PRÜFUNG, (BAM) (DE) 2026-04-21 US claimed
US-12600746-B2 Synthetic methods using native chemical ligation in flow THE UNIVERSITY OF SYDNEY (AU) 2026-04-14 US claimed
CN-121583230-A Method for widening sound absorption frequency band of microperforated panel sound absorber array under excitation of free field oblique incidence plane wave 西北工业大学 2026-02-27 CN claimed
US-20250346938-A1 ATP-DEPENDENT C-TERMINAL MODIFICATION OF POLYPEPTIDES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2025-11-13 US claimed
CN-120081920-A Disulfide bond-containing polypeptide and preparation method and application thereof 中国科学院上海药物研究所 2025-06-03 CN claimed
CN-120004798-A Double-functional connecting agent, N-terminal site-directed PEGylated protein, preparation process thereof and application thereof in preparation of anti-hepatitis B virus drugs 上海市重大传染病和生物安全研究院 2025-05-16 CN claimed
EP-4523270-A1 FLOW BATTERY WITH A DYNAMIC FLUIDIC NETWORK Lockheed Martin Energy, LLC (US) 2025-03-19 EP claimed
CN-119461939-A Sulfate erosion resistant polycarboxylate superplasticizer and preparation method and application thereof 陕西科之杰新材料有限公司 2025-02-18 CN claimed
CN-119447155-A Preparation method of zinc negative electrode of hydrophobic and zinc-philic mercapto functional treatment zinc ion energy storage device 南京航空航天大学 2025-02-14 CN claimed
CN-119446106-A Active control method for improving low-frequency sound absorption performance of microperforated panel sound absorber array under free field normal incidence excitation 西北工业大学 2025-02-14 CN claimed
EP-2197895-A2 METHODS AND INTERMEDIATES FOR CHEMICAL SYNTHESIS OF POLYPEPTIDES AND PROTEINS IPSEN PHARMA S.A.S. (FR) 2010-06-23 EP claimed
EP-2195329-A2 METHODS AND INTERMEDIATES FOR CHEMICAL SYNTHESIS OF POLYPEPTIDES AND PROTEINS IPSEN PHARMA S.A.S. (FR) 2010-06-16 EP claimed
US-7674881-B2 Convergent synthesis of proteins by kinetically controlled ligation THE UNIVERSITY OF CHICAGO (US) 2010-03-09 US claimed
WO-2009104836-A1 A GLUCOSE SENSOR COMPRISING GLUCOSE OXIDASE VARIANT KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-08-27 WO claimed
WO-2009032181-A2 METHODS AND INTERMEDIATES FOR CHEMICAL SYNTHESIS OF POLYPEPTIDES AND PROTEINS IPSEN PHARMA S.A.S. (FR) 2009-03-12 WO claimed
WO-2009032133-A2 METHODS AND INTERMEDIATES FOR CHEMICAL SYNTHESIS OF POLYPEPTIDES AND PROTEINS IPSEN PHARMA S.A.S. (FR) 2009-03-12 WO claimed
US-20080176212-A1 All optical nanoscale sensor WILLIAM MARSH RICE UNIVERSITY (US) 2008-07-24 US claimed
WO-2007100358-A2 CONVERGENT SYNTHESIS OF PROTEINS BY KINETICALLY CONTROLLED LIGATION UNIVERSITY OF CHICAGO (US) 2007-09-07 WO claimed
US-20070082378-A1 Convergent synthesis of proteins by kinetically controlled ligation UNIVERSITY OF CHICAGO (US) 2007-04-12 US claimed
US-4826888-A STORAGE STABLE, DISCOLORATION INHIBITION MITSUBISHI RAYON CO., LTD. (JP) 1989-05-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605695-B2 Molecularly imprinted fluorescent polymers for direct detection of glyphosate, its degradation products, and metabolites GRIN3A, PAM, GYPA CA2 2194/4885CAMK2A 2390/4885AKR1B1 4707/4885
US-20070082378-A1 Convergent synthesis of proteins by kinetically controlled ligation NPEPPS, PTMS, QPCTL CA2 2739/4885CAMK2A 1450/4885AKR1B1 2891/4885
US-12600746-B2 Synthetic methods using native chemical ligation in flow SCLY, CTH, CBS CA2 2463/4885CAMK2A 4594/4885AKR1B1 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.